Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="PARIDAENS, R*" or (type exact bookEditor and editor="PARIDAENS, R*")

Add to list
- Journal Article
- A1
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

O ABE, R ABE, K ENOMOTO, K KIKUCHI, H KOYAMA, H MASUDA, Y NOMURA, K SAKAI, K SUGIMACHI, T TOMINAGA, et al.

(2005) LANCET. 365(9472). p.1687-1717
Add to list
- Journal Article
- A1
Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

Simon Van Belle (UGent) , R PARIDAENS, G EVERS, J KERGER, D BRON, J FOUBERT, G PONNET, DV STEICHEL, C HEREMANS and D ROSILLON

(2005) SUPPORTIVE CARE IN CANCER. 13(4). p.246-254
Add to list
- Journal Article
- A1
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

R PARIDAENS, L DIRIX, C LOHRISCH, L BEEX, M NOOIJ, D CAMERON, L BIGANZOLI, T CUFER, Luc Duchateau (UGent) , A HAMILTON, et al.

(2003) ANNALS OF ONCOLOGY. 14(9). p.1391-1398
Add to list
- Journal Article
- A1
COMPARISON OF THE ANTIEMETIC EFFICACY OF DIFFERENT DOSES OF ONDANSETRON, GIVEN AS EITHER A CONTINUOUS INFUSION OR A SINGLE INTRAVENOUS DOSE, IN ACUTE CISPLATIN-INDUCED EMESIS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP-STUDY.

C SEYNAEVE, J SCHULLER, K BUSER, H PORTEDER, S VANBELLE, P SEVELDA, D CHRISTMANN, M SCHMIDT, H KITCHENER, D PAES, et al.

(1992) BRITISH JOURNAL OF CANCER. 66(1). p.192-197

← Previous

Academic Bibliography

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

COMPARISON OF THE ANTIEMETIC EFFICACY OF DIFFERENT DOSES OF ONDANSETRON, GIVEN AS EITHER A CONTINUOUS INFUSION OR A SINGLE INTRAVENOUS DOSE, IN ACUTE CISPLATIN-INDUCED EMESIS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP-STUDY.

Contents

Support

Contact